UK Enforces Indefinite Ban on Puberty Blockers for Minors
The UK government has announced an indefinite ban on puberty blockers for under-18s with gender dysphoria, except in clinical trials, citing safety concerns. This decision follows advice from the Commission on Human Medicines and aligns with recommendations from the Cass Review. The ban, which applies across the UK, aims to ensure child safety and evidence-based care, though it has faced criticism from trans rights advocates. Current patients will continue to receive treatment, and a clinical trial is planned to establish an evidence base for the medication's use.